Allworth Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Allworth Financial’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-24	Closed	-$2K	–	3287
2022 Q3	$2K	Buy	+24	New	+$1.32K	﹤0.01%	2283
2022 Q1	–	Sell	-324	Closed	-$9K	–	2472
2021 Q4	$9K	Buy	+324	New	+$10K	﹤0.01%	1441

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allworth Financial's GBT Position: Q4 2022 in Review

Allworth Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 24 shares — an estimated $2K sold.

Allworth Financial first reported a position in GBT in Q4 2021 and held it in 2 quarters. The position peaked at $9K in Q4 2021. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Allworth Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Allworth Financial sold 24 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $2K.
Allworth Financial first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 2 quarters.
Allworth Financial's Global Blood Therapeutics, Inc. position peaked at $9K in Q4 2021.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Allworth Financial's 13F filing for Q4 2022, filed 13 Jan 2023.